January: Acupuncture
January: Hawaii's Vaccination Plan
January: Medicaid Eligibility For Freely Associated States Under The Compact Of Free Association (COFA) Citizens
February: COVID-19 Pandemic-Related Flexibilities Offered by Med-QUEST
February: Non-Emergent Medical Transportation (NEMT) Scheduling Transitioning To IntelliRide - Updated: 3/24/21
April: Community Care Foster Family Home (CCFFH) and Expanded Adult Residential Care Home (EARCH) - IMPORTANT CLAIMS SUBMISSION UPDATES
April: FDA recommends avoiding use of NSAIDs in pregnancy at 20 weeks or later
April: Studies show increased risk of heart rhythm problems with seizure and mental health medicine (Lamictal) in patients with heart disease
April: FDA warns about serious problems with high doses of the allergy medicine Benadryl
May: New Pharmacy Benefits Manager - IngenioRx (beginning 7/1/2021)
June: REMINDER: New Pharmacy Benefits Manager - IngenioRx (beginning 7/1/2021)
July: REMINDER: Provider Relief Fund Post-payment Reporting Requirements
July: FDA restricts use of Ocaliva in PBC patients with advanced cirrhosis
July: FDA warns that abuse and misuse of the nasal decongestant propylhexedrine causes serious harm
July: FDA requests removal of strongest warning against cholesterol-lowering statins during pregnancy
September: Prior Authorization Changes for Specific Durable Medical Equipment (DME)
October: Buprenorphine for Chronic Pain
October: Safe Opioid Prescribing Practices
March: 100 Days Supply Coverage for Medicare Maintenance Drugs
May: Diabetic Testing Supplies
June: New Implementation - IngenioRx and CVS Caremark
September: Important Information for Claims Processing
September: Coordination of Benefits Change
November: Medicare 2022 Formulary Impacts & Walgreens Added to QUEST Pharmacy Network
December: CVS Caremark to process claims for AlohaCare Advantage Plus (HMO SNP)
March: Important COVID-19 Notification
April: New Boxed Warning: montelukast (Singulair) and Mental Health Side Effects
April: Updated List of Covered Telehealth Services and Other Important Notifications Related to COVID-19
May: Medicare Quality Measures: CMS Part D Star Ratings
July: COVID-19: Nebulizer Use During the Pandemic
July: Prior Authorizations
July: CARES Act Provider Relief Fund
August: CARES Act Provider Relief Fund Application Deadline Extended!
September: Drug Management Program, a Pharmacy Home & Designated Prescriber for Opioid Therapy
September: Medication Adherence & Statin Use in Diabetics -- a Member Outreach Campaign
September: Opioid Utilization & Morphine Milligram Equivalents (MME)
October: 2020 Annual Plan Change Information for Providers
October: COVID-19 Public Health Emergency Extended
October: Non-Emergent Medical Transportation
November: Prior Authorization Changes
December: AlohaCare Substance Abuse Prior Authorization Changes
December: Electronic Visit Verification (EVV) Implementation Clarifying Information
March: Update on Adaptive Behavior Services
May: Medicare Advantage and QUEST Integration Reimbursement Guidelines for LMFT and LMHCBehavioral Health Providers
June: Changes to Prior Authorization List
June: Asthma Management & Albuterol Quantity Limits
July: Diabetic Testing Supplies
August: Electronic Prior Authorization (ePA) for Medicare (AlohaCare Advantage Plus)
August: Accredo Specialty Pharmacy
September: Implementation of Patient Driven Payment Model (PDPM) andPatient Driven Groupings Model (PDGM)
September: FDA Warns About Serious Liver Injury with Some Hepatitis C Medicines
September: FDA Adds Warning for Certain Insomnia Medicines
October: New Morphine Milligram Equivalents
October: Our Care Our Choice Act
December: FDA warns about rare but severe lung inflammation with Ibrance, Kisquali, and Verzenio for breast cancer
December: FDA identifies harm reported from sudden discontinuation of opioid pain medicines
December: CDC Guideline for Prescribing Opioids for Chronic Pain
December: FDA approves Boxed Warning about increased risk of blood clots with higher does of arthritis and ulcerative colitis medicine tofacitinib (Xeljanz, Xeljanz XR)
December: FDA adds Boxed Warning for increased risk of death with gout medicine Uloric (febuxostat)
December: Opioids and Benzodiazepines
June: PT/OT Prior Authorization Policy
July: Change in Referral Policy
October: Change in Prior Authorization Policy
November: Flu Vaccine and Colorectal Screenings
2. May: AlohaCare National Drug Codes Billing Requirements 3. October: Unlicensed Behavioral Health Providers in FQHCs and RHCs
July: ICD-10 Transition
September: ICD-10 Claims
November
October
September
AlohaCare Advantage (HMO) Medicare Health Plan
Provider Education Session (Hilo)
May
April
February
CMS 1500 Claim Form
Quarter 3 2021
Quarter 2 2021
Quarter 1 2021
Quarter 3 2020
Quarter 2 2020
Quarter 4 2019
Quarter 3 2019
Quarter 2 2019
Quarter 1 2019
Quarter 4 2018
Quarter 3 2018
Quarter 2 2018
Quarter 1 2018
Quarter 4 2017
Quarter 3 2017
Quarter 2 2017
Quarter 1 2017